Bioequivalence study of ondansetron tablets by HPLC-MS
Abstract
About the Authors
E. S. StepanovaRussian Federation
M. V. Ovcharov
Russian Federation
S. S. Barsegyan
Russian Federation
S. M. Nikonova
Russian Federation
V. V. Shilov
Russian Federation
V. V. Chistyakov
Russian Federation
References
1. Kris M.G., Hesketh P.J., Herrstedt J., Rittenberg C., Einhorn L.H., Grunberg S. et al. Consensus proposals for the prevention of acute and delayed vomiting and nausea following high - emetic - risk chemotherapy. // Support Care Cancer 2005, Vol. 13:85-96.
2. Oge A., Alkis N., Oge O., Kartum A. Comparison of granisetron, ondansetron and tropisetron for control of vomiting and nausea induced by cisplatin. // J Chemother 2000, Vol. 12(1):105-108.
3. Steven M. Grunberg, and Paul J. Hesketh. Control of Chemotherapy-Induced Emesis. // The New England journal of medicine, 1993, Vol. 329:1790-1796.
4. Stiakaki E., Savvas S., Lydaki E., Bolonaki I., Kouvidi E., Dimitriou H., et al. Ondansetron and tropisetron in the control of nausea and vomiting in children receiving combined cancer chemotherapy. // Pediatr Hematol Oncol. 1999, Vol. 16(2):101-108.
5. Yara Popst Armando, Simone Grigoleto Schramm, Marina de Freitas Silva, Eunice Kazue Kano. Bioequivalence assay between orally disintegrating and conventional tablet formulations in healthy volunteers. // International Journal of Pharmaceutics, 2009, Vol. 366, 149-153.
6. Guideline on bioanalytical method validation. // European Medicines Agency, 2011.
7. Методические рекомендации «Изучение биоэквивалентности воспроизведенных лекарственных средств, гл. 7 в «Руководство по экспертизе лекарственных средств. Том I. - М.: Гриф и К, 2013.
Review
For citations:
Stepanova E.S., Ovcharov M.V., Barsegyan S.S., Nikonova S.M., Shilov V.V., Chistyakov V.V. Bioequivalence study of ondansetron tablets by HPLC-MS. Pharmacokinetics and Pharmacodynamics. 2015;(1):21-26. (In Russ.)